Medicare Rx Funding Amount Is In Question Until Tax Cut Resolved - Wilensky
Executive Summary
The amount of money left to fund a Medicare prescription drug benefit is a question that will not be answered until the size of the proposed tax cut is resolved, former Bush campaign advisor Gail Wilensky, PhD, indicated Feb. 1.
You may also be interested in...
Rx Reimportation Push Resumes: Gutknecht Sees Open Borders As Inevitable
Personal importation of prescription drugs will inevitably lead to reimportation at the wholesale level, Rep. Gutknecht (R-Minn.) suggested at a Washington, D.C., press conference Jan. 31.
Rx tax deductions
Restoration of federal tax deductions for out-of-pocket pharmaceutical expenses is among the top legislative priorities for the National Community Pharmacists Association in the 107th Congress. A Jan. 19 letter from NCPA to drug manufacturers asks them to support introduction of a "Consumer Medicine Tax Relief Act," which would provide "first-dollar deductibility of prescription drugs, OTC drugs, and pharmacist professional services under the federal tax code." NCPA is pushing the tax measure because it believes "a vigorous debate on tax reform" is likely to come before debate on Medicare reform
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011